SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-006784
Filing Date
2022-06-17
Accepted
2022-06-17 19:28:54
Documents
1
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 form4-06172022_040644.html 4  
1 form4-06172022_040644.xml 4 4252
  Complete submission text file 0001415889-22-006784.txt   5600
Mailing Address SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
CLARK IAN T (Reporting) CIK: 0001336504 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39712 | Film No.: 221025571

Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations